DAY 1 - Saturday, April 21
Welcome
Ophthalmology Times welcomes ophthalmic professionals from around the world to Chicago. Our four-day coverage of this year’s meeting of the American Society of Cataract and Refractive Surgery begins today and includes the latest research findings and clinical news of interest to readers.
Enjoy the meeting!
CORNEA DAY
Surgeons urged to embrace DMEK as major advance
Chicago—Descemet’s membrane endothelial keratoplasty (DMEK) is now ready for prime time and should be offered to appropriately selected patients needing a corneal graft for endothelial dysfunction because it represents the best available care, said Francis W. Price Jr., MD. » MORE
Toric IOL viable option for keratoconus
Chicago—Emerging experience suggests the boundaries for toric IOL implantation can be expanded to include carefully selected eyes with keratoconus, said Alejandro Navas, MD, MSc. » MORE
Infectious keratitis responds to riboflavin crosslinking
Chicago—Corneal collagen crosslinking (CXL) with ultraviolet A (UVA) light and riboflavin is promising therapy for infectious keratitis caused by a variety of pathogens, said J. Bradley Randleman, MD. » MORE
New dry eye test assays marker of inflammation
Chicago—A new test for identifying ocular surface inflammation by detecting matrix metalloproteinase-9 (MMP-9) in the tears is an excellent tool to help clinicians diagnose dry eye disease in patients who do not demonstrate the classic clinical findings of this ocular surface condition, said Stephen C. Kaufman, MD, PhD. » MORE
GLAUCOMA DAY
Restoring aqueous flow in early glaucoma
Chicago—Robert Stegmann, MD, has spent years working on a procedure to reverse glaucoma. He demonstrated the results of canaloplasty to reinstitute aqueous flow in eyes with no flow and severely high IOP values. Dr. Stegmann, professor and chairman, Medical University of South Africa, Pretoria, delivered the Stephen A. Obstbaum, MD, Honored Lecture, titled “The Time Has Come, the Walrus Said . . . to Cure Glaucoma.” » MORE
Glaucoma risk factors: When to initiate therapy
Chicago—Initiating medical therapy for patients with ocular hypertension or with suspected glaucoma should include careful history taking and examination, testing, and discussion with patients, said Paul Harasymowycz, MD. » MORE
Real-world strategies increase medication compliance
Chicago—Compliance with medical regimens for glaucoma decreases over time, and patients receiving more than one medication have lower rates of compliance. Despite advances in glaucoma therapy, such as once-daily dosing and dosing aids, patient compliance has not improved, said Douglas J. Rhee, MD. » MORE
Steering patients toward visual rehabilitation
Chicago—Ophthalmologists generally advise their patients to seek visual rehabilitation services when patients have moderate to severe glaucoma, said Mary Lou Jackson, MD. » MORE
FROM THE SHOW FLOOR
AMO iFS laser receives FDA clearance for arcuate incisions
Chicago—Abbott Medical Optics (AMO) announced FDA clearance to use its iFS advanced femtosecond laser to create bow-shaped or curved arcuate incisions in corneal surgery, including cataract surgery. » MORE
HOYA clear optic IOLs gain FDA approval
Chicago—HOYA Surgical Optics Inc. announced it received FDA approval for the commercial distribution of two models of clear foldable hydrophobic acrylic-optic aspheric IOLs, the iSymm (Model FC-60AD) and the preloaded iSert (Model PC-60AD), in the United States. » MORE
DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.
|
